Cartesian Therapeutics
RNAC
RNAC
65 hedge funds and large institutions have $178M invested in Cartesian Therapeutics in 2018 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 27 increasing their positions, 15 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
14% more funds holding
Funds holding: 57 → 65 (+8)
0.08% more ownership
Funds ownership: 1.62% → 1.7% (+0.08%)
Holders
65
Holding in Top 10
2
Calls
$1.44M
Puts
–
Top Buyers
| 1 | +$3.16M | |
| 2 | +$2.33M | |
| 3 | +$957K | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$933K |
| 5 |
PVI
Pura Vida Investments
New York
|
+$905K |
Top Sellers
| 1 | -$2.33M | |
| 2 | -$1.24M | |
| 3 | -$439K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$389K |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$301K |